TuHURA Biosciences (HURA) Interest & Investment Income (2013 - 2026)
TuHURA Biosciences (HURA) posted quarterly Interest & Investment Income of $21275.0 for Q1 2026, down 78.75% year-over-year from $100098.0 in Q1 2025, and up 3393.43% quarter-over-quarter from $609.0 in Q4 2025.
TuHURA Biosciences (HURA) Interest & Investment Income (2013 - 2026) Analysis & Trends
TuHURA Biosciences' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $21275.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 78.75% year-over-year to $21275.0; the TTM figure through Mar 2026 stood at $57410.0 (down 84.44% YoY), while the FY2025 annual figure was $136233.0, down 62.33% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $21275.0, up from $609.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $197449.0 in Q3 2024, with the low at $609.0 in Q4 2025.
- The 3-year median for Interest & Investment Income is $25370.5 (2025), against an average of $53285.1.
- Peak annual rise in Interest & Investment Income reached 1407.05% in 2025, while the deepest fall reached 96.93% in 2025.
- TuHURA Biosciences' Interest & Investment Income stood at $197449.0 in 2024, then slumped by 99.69% to $609.0 in 2025, then soared by 3393.43% to $21275.0 in 2026.
- Business Quant data shows HURA's Interest & Investment Income at $21275.0 in Q1 2026, $609.0 in Q4 2025, and $6060.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | 7,620.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,275.00 |
| Dec 31, 2025 | 609.00 |
| Sep 30, 2025 | 6,060.00 |
| Jun 30, 2025 | 29,466.00 |
| Mar 31, 2025 | 100,098.00 |
| Sep 30, 2024 | 197,449.00 |
| Jun 30, 2024 | 64,682.00 |
| Mar 31, 2024 | 6,642.00 |
| Mar 31, 2019 | 13,397.00 |
| Dec 31, 2018 | 16,272.00 |
| Sep 30, 2018 | 19,844.00 |
| Mar 31, 2018 | 5,850.00 |
| Dec 31, 2017 | 235.00 |
| Sep 30, 2017 | 156.00 |
| Mar 31, 2017 | 148.00 |
| Dec 31, 2016 | 60.00 |
| Sep 30, 2016 | 41.00 |
| Jun 30, 2016 | 179.00 |
| Mar 31, 2016 | -41.00 |
| Dec 31, 2015 | 10.00 |